Quantcast

Latest Intermezzo Stories

2014-07-01 08:29:02

Merger to result in NASDAQ-listed biopharmaceutical company whose lead asset is a novel Phase 3-ready, oral and intravenous antibiotic drug candidate designed to address the treatment needs of patients with serious community-acquired bacterial infections. BOSTON, Mass., and POINT RICHMOND, Calif., July 1, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) and Paratek Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced today that they have entered into...

2014-05-29 23:11:34

A Romantic Story of a Physician and a World Famous Opera Singer Wynnewood, PA (PRWEB) May 29, 2014 “An opera begins long before the curtain goes up and ends long after it has come down. It starts in my imagination, it becomes my life, and it stays part of my life long after I've left the opera house.” – Maria Callas For the fictitious physician Vip Van Buren, the opera becomes a significant part of his life after a chance encounter with the world’s most famous opera singer,...

2014-05-14 08:31:17

POINT RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Transcept Pharmaceuticals Inc. (NASDAQ: TSPT) announced today that its board of directors declared a special cash dividend of $1.33 per share on the Company's common stock. Payment will be made on June 3, 2014, to stockholders of record at the close of business on May 26, 2014. "We are pleased to distribute a significant amount of cash to our stockholders, and we continue to explore a range of alternatives to enhance stockholder...

2014-05-05 16:27:36

POINT RICHMOND, Calif., May 5, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three months ended March 31, 2014. Transcept reported cash, cash equivalents and marketable securities of $69.8 million at March 31, 2014. "We continue to explore a...

2014-01-13 20:21:44

POINT RICHMOND, Calif., Jan. 13, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced the dismissal of the derivative lawsuit by the Court of Chancery of the State of Delaware. The derivative lawsuit was filed on October 24, 2013, by a shareholder, Retrophin Inc., against the Transcept Board of Directors, purporting to assert claims on behalf of Transcept, alleging that our Board of Directors approved and paid excessive compensation to our directors....


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related